# Dr. Reddy's Laboratories Limited (RDY): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/rdy for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic
- Exchange: NYSE · Trading currency: USD

Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Service...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $13.21 USD |
| Market Cap | $11.00B |
| P/E (TTM) | 33.02 |
| EPS (TTM) | $0.40 |
| 52-Week Range | $11.36 – $15.67 |
| Dividend Yield (TTM) | 0.63% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 0.63% |
| Annual Dividend (TTM) | $0.08 /share |
| Annual Dividend (Forward) | $0.08 /share |
| Frequency | Annual |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | -8.8% / -27.7% / 4.4% / 3.4% |
| Payout Ratio (EPS, TTM) | 23.7% |
| Payout Ratio (FCF, TTM) | 55.3% |
| Payout Ratio (EPS, forward dividend) | 23.7% |
| Payout Ratio (FCF, forward dividend) | 55.3% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-07-24 | $0.0834 | 2026-08-05 |
| 2025-07-25 | $0.0915 | 2025-08-06 |
| 2024-07-30 | $0.0808 | 2024-08-12 |
| 2023-07-28 | $0.0965 | 2023-08-11 |
| 2023-07-07 | $0.0976 | 2023-08-11 |
| 2022-08-01 | $0.0757 | 2022-08-12 |
| 2022-07-08 | $0.0774 | 2022-07-11 |
| 2021-07-09 | $0.0673 | 2021-08-11 |
| 2020-07-10 | $0.0667 | 2020-08-17 |
| 2019-07-12 | $0.0564 | 2019-08-15 |
| 2018-07-13 | $0.0584 | 2018-08-09 |
| 2017-07-13 | $0.2939 | 2017-08-10 |

Full history: https://www.dividenddata.com/stocks/rdy/dividend

## Frequently Asked Questions

### What does Dr. Reddy's Laboratories Limited do?

Dr. Reddy's Laboratories Limited (RDY) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is RDY's market cap?

Dr. Reddy's Laboratories Limited (RDY) has a market capitalization of approximately $11.00 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does RDY pay a dividend?

Yes, Dr. Reddy's Laboratories Limited (RDY) pays a dividend annually, with a trailing-twelve-month yield of 0.63%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does RDY pay dividends?

Dr. Reddy's Laboratories Limited pays dividends annually. The forward annual rate is $0.08 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is RDY's payout ratio?

Dr. Reddy's Laboratories Limited's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/rdy
- Dividend history & safety: https://www.dividenddata.com/stocks/rdy/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/rdy/earnings
- Financial statements: https://www.dividenddata.com/stocks/rdy/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/rdy/valuation
- Peer comparison: https://www.dividenddata.com/stocks/rdy/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.